News
CorMedix (CRMD) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
CorMedix (NASDAQ: CRMD)Q2 2024 Earnings CallAug 14, 2024, 8:30 a.m. ET
Operator
Source Fool.com
Why Victoria's Secret Stock Was Climbing Today
Shares of Victoria's Secret (NYSE: VSCO) were surging today after the struggling apparel company named a new CEO, Hillary Super. Investors seem to be hopeful that the move will lead to a turnaround
RAMQ Expands Provincial Coverage to Include Dexcom G7, Bringing the Next-Generation CGM System to More Québec Residents
Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced today that its latest innovation, the Dexcom G7 Continuous
EQS-News: Evotec SE reports H1 2024 results: Challenging year; priority reset for sustainable profitable growth gaining momentum, building on core strengths
EQS-News: Evotec announces strong progress in strategic protein degradation partnership with Bristol Myers Squibb
Abbott Laboratories Stock Could Soar to $143, According to a Wall Street Analyst. Is It a Buy Around $108?
According to a bullish Wall Street analyst, Abbott Laboratories (NYSE: ABT) stock could outperform for investors. Following the company's latest earnings report, Matt Miksic from Barclays maintained
Prediction: Buying Biotech and Pharma Stocks During This Sell-Off Will Be a Smart Move
The market is a bit jittery right now thanks to a confluence of factors, including a weaker-than-anticipated U.S. jobs report, international geopolitical issues, and foreign currency disruptions --
3 Reliable Dividend Stocks With Yields Above 5% That You Can Buy With $100 Now
Would you like to improve your passive income stream but don't have a lot of extra cash to throw around? If so, I have great news: These days, $100 is all it takes to acquire a share of three top
Is Pfizer Stock a Buy Now After Earnings?
While the COVID-19 pandemic is an increasingly distant memory for most investors, Pfizer (NYSE: PFE) has struggled to move past the overhang of record vaccine sales and earnings in 2021 and 2022
A Blood Test Could Detect Early Alzheimer's. That Could Make These 2 Stocks Red-Hot Buys.
One thing that can help with the treatment of any disease is early detection, and Alzheimer's is no exception to that. And the good news is that in the near future, detecting cases of Alzheimer's
Prediction: Rocket Lab Gets a New Neighbor in SpaceX
Five years ago -- even before its IPO -- small rocket company and SpaceX rival Rocket Lab USA (NASDAQ: RKLB) had an announcement to make.
Despite its name, Rocket Lab was primarily a New Zealand
Forget Nvidia: Buy This Magnificent Artificial Intelligence (AI) Stock Instead
There's no denying Nvidia has been the centerpiece of the artificial intelligence (AI) revolution thus far. Its technology is used in the vast majority of the world's AI platforms simply because it
3 Stocks Retirees Should Absolutely Love
Many retirees are investors for a good reason: They can't rely entirely on Social Security to fund their retirement. Investing wisely provides a means to retire comfortably.
Three Motley Fool
EQS-News: STRATEC POSTS RESULTS FOR FIRST HALF OF 2024
Agenus (AGEN) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Agenus (NASDAQ: AGEN)Q2 2024 Earnings CallAug 08, 2024, 8:30 a.m. ET
Operator
Source Fool.com
Geron (GERN) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Geron (NASDAQ: GERN)Q2 2024 Earnings CallAug 08, 2024, 8:00 a.m. ET
Operator
Source Fool.com
Why Viatris Stock Is Jumping Today
Shares of Viatris (NASDAQ: VTRS) were jumping 6% higher as of 11:18 a.m. ET on Thursday after rising as much as 12.4% earlier in the day. The solid gain came after the global healthcare company
Should You Buy DexCom Stock After Its Post-Earnings Sell-Off?
When a stock falls over a cliff after earnings, it can put investors into an unnerving situation: Should you average down, or simply get out of the stock entirely? It's not always an easy question
These Stocks Just Dropped by 40% and 15% -- Should You Buy the Dip?
Earnings season can be a volatile time in the stock market. Some corporations produce financial results that are impressive enough to send their share prices soaring, while others move in the exact
Should Pfizer's Strong Quarter Calm Investor Concerns About the Stock?
Demand for COVID-19 vaccines and drugs has been fading for a while now. And that has put a big dent in Pfizer's (NYSE: PFE) sales and profit numbers. On top of that, the stock is also facing
2 Dividend Stocks to Double Up on Right Now
When the stock market gets choppy, it can be nice to have extra cash regularly deposited in your account. Let's look at two top stocks that pay regular dividends to shareholders. These profitable
Here's Why Eli Lilly Stock Dropped 12% Last Month
Shares of Eli Lilly (NYSE: LLY) fell 20% in July, according to data from S&P Global Market Intelligence. The pharmaceutical stock tumbled after one of the company's competitors announced promising
EQS-News: First half of 2024: RHÖN-KLINIKUM AG continues good business performance – outlook confirmed
Sarepta Therapeutics (SRPT) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Sarepta Therapeutics (NASDAQ: SRPT)Q2 2024 Earnings CallAug 07, 2024, 4:30 p.m. ET
Operator
Source Fool.com
EQS-News: Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb